Search Browse Earnings

Tevogen Bio Holdings Inc.

Nasdaq:TVGNNasdaq:TVGNW

Biological Products, (No Diagnostic Substances)·WARREN, NJ

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Tevogen Bio Holdings Inc. — SlamSEC

Revenue

—

Adj. EBITDA

-$8.7M

FY 2024

Net Income

-$60.5M

FY 2024

EPS (Diluted)

-$2.44

FY 2024

Stock Price

$7.05

2026-03-06

52W Range

—

P/E Ratio

-2.9x

Market Cap

$1.4B

Cash

$0

FY 2024

Total Debt

—

Net Debt

$0

FY 2023

Enterprise Value

$1.4B

Debt / EBITDA

0.0x

FY 2024

EV / EBITDA

-161.4x

Employees

—

CEO

Saadi Ryan H.

CFO

Desai Kirti